Taiho Pharma / Exelixis Deal History & Licensing Activity
Taiho Pharma / Exelixis is a life sciences. Over the past three years, Taiho Pharma / Exelixis has been involved in 1 licensing and acquisition transaction, with a primary focus on ADC (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
ADC
Focus Area
Women's Health
Taiho Pharma / Exelixis Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Taiho Pharma / Exelixis in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Araris ADC platform | Araris | ADC | Unknown | collaboration | May 2026 |
Taiho Pharma / Exelixis Pipeline Focus
Therapeutic areas and modalities where Taiho Pharma / Exelixis is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Taiho Pharma / Exelixis's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Women's Health assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Taiho Pharma / Exelixis Licensing & Deal Activity
Taiho Pharma / Exelixis is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Taiho Pharma / Exelixis ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Taiho Pharma / Exelixis include Women's Health (2 deals and trials). In terms of modality, Taiho Pharma / Exelixis has shown particular interest in adc.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Taiho Pharma / Exelixis and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Taiho Pharma / Exelixis's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.